Responding to the evidence for the management of severe malaria

Tropical Medicine and International Health

Volumn 16, Issue 9, 2011, Pages 1085-1086

  Ford, Nathan P ^a,b   de Smet, Martin ^a   Kolappa, Kavitha ^a,c   White, Nicholas J ^d  

^a MÉDECINS SANS FRONTIÈRES   (Belgium)

^b Centre for Infectious Disease Epidemiology and Research   (South Africa)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Artesunate; Quinine; Severe malaria; Treatment

Indexed keywords

ARTEMISININ; CHLOROQUINE; QUININE;

COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EDITORIAL; HEALTH CARE PLANNING; HUMAN; MALARIA; MORTALITY; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; ARTEMISININS; CRITICAL ILLNESS; EVIDENCE-BASED PRACTICE; HEALTH CARE COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMATION DISSEMINATION; MALARIA; PRACTICE GUIDELINES AS TOPIC; QUININE; TRAINING SUPPORT; WORLD HEALTH ORGANIZATION;

ARTESUNATE;

EID: 79961165734     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2011.02810.x     Document Type: Editorial

References (14)

1. Amuasi JH, Diap G, Blay-Nguah S et al. (2011) Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi. Malaria Journal 10, 34.
2. Attaran A, Barnes K, Curtis C et al. (2004) WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363, 237-240.
3. Butler A, Kahn S & Ferguson E (2010) A brief history of malaria chemotherapy. The Journal of the Royal College of Physicians of Edinburgh 40, 172-177.
4. CIOMS (2002) Council of International Organizations of Medical Sciences: International Ethical Guidelines for Biomedical Research Involving Human Subjects.
5. Dondorp A, Nosten F, Stepniewska K, Day N & White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group (2005) Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366, 717-725.
6. Dondorp AM, Fanello CI, Hendriksen IC et al. ; AQUAMAT group (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376, 164.
7. Guthmann J-P, Checchi F, van den Broek I et al. (2008) Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières. PLoS Medicine 5, e169.
8. Lubell Y, Yeung S, Dondorp AM et al. (2009) Cost-effectiveness of artesunate for the treatment of severe malaria. Tropical Medicine and International Health 14, 332-337.
9. Lubell Y, Riewpaiboon A, Dondorp AM et al. (2011) Cost-effectiveness of parenteral artesunate for the treatment of children with severe malaria in Sub-Saharan Africa. Bulletin of the World Health Organization in press.
10. MSF (2011) Making the Switch: Ensuring Access to Improved Treatment for Severe Malaria in Africa. MSF, Geneva.
11. Sinclair D, Donegan S & Lalloo DG (2011) Artesunate versus quinine for treating severe malaria. Cochrane Database of Systematic Reviews 3, CD005967.
12. Snow R, Okiro E, Gething P, Atun R & Hay S (2010) Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments. Lancet 376, 1409-1416.
13. WHO (2010) World Malaria Report. WHO, Geneva.
14. WHO (2011) Guidelines for the Treatment of Severe Malaria, 2nd edn. WHO, Geneva.